A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Pfizer
iOnctura
St. Jude Children's Research Hospital
OncoNano Medicine, Inc.
Arcus Biosciences, Inc.
Novartis
Shattuck Labs, Inc.
GlaxoSmithKline
Seagen Inc.
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
National Cancer Institute (NCI)
Celldex Therapeutics
Eisai Inc.
TopAlliance Biosciences
Stanford University
Deciphera Pharmaceuticals, LLC
Rutgers, The State University of New Jersey
NovalGen Ltd.
Seagen Inc.
Fate Therapeutics
Sierra Oncology LLC - a GSK company
Pfizer
Repertoire Immune Medicines
Incyte Corporation
Celgene
Memorial Sloan Kettering Cancer Center
Pfizer
Tocagen Inc.
Lytix Biopharma AS
Celldex Therapeutics
Celgene
Mirna Therapeutics, Inc.
Bayer
Rutgers, The State University of New Jersey
The Cleveland Clinic
University of Chicago
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)